St. Anna Kinderkrebsforschung

🇦🇹Austria

Country: 🇦🇹Austria

Ownership: -

Established: 1986-01-01

Employees: -

Market Cap: -

Website: https://kinderkrebsforschung.at

Clinical Trials

COVID-19: Infectious Potential of SARS-CoV-2 Intestinal Shedding in Pediatric Patients (INPOSIS)

Completed

Conditions: SARS-CoV-2 Infection
Intestinal Infection
Covid19

First Posted Date: 2021-09-24

Last Posted Date: 2024-12-09

Lead Sponsor: St. Anna Kinderkrebsforschung

Target Recruit Count: 283

Registration Number: NCT05055466

Locations: 🇦🇹
St.Anna Children´s Hospital, Vienna, Austria(AUT), Austria
🇦🇹
University Hospital Krems, Krems, Austria
🇦🇹
University Hospital Tulln, Tulln, Austria

and more 1 locations

Allogeneic Stem Cell Transplantation for Children With CML

Phase 2

Completed

Conditions: Chronic Myeloid Leukemia

Interventions: Drug: Fludarabine
Drug: Thiotepa
Drug: Melphalan
Drug: ATG
Drug: Cyclosporine A
Drug: Mycophenolate mofetil
Biological: bone marrow or peripheral blood stem cells

First Posted Date: 2016-03-14

Last Posted Date: 2021-04-15

Lead Sponsor: St. Anna Kinderkrebsforschung

Target Recruit Count: 13

Registration Number: NCT02707393

Locations: 🇦🇹
Universitätsklinik für Kinder- und Jugendheilkunde, Graz, Austria
🇨🇿
Hospital Motol, Department of Pediatric Hematology and Oncology, BMT Unit, Praha, Czechia
🇦🇹
St. Anna Kinderspital, Wien, Austria

and more 1 locations

Virus-specific ImmunoTherapy Following Allogeneic Stem Cell Transplantation

Phase 1

Withdrawn

Conditions: Cytomegalovirus Infection
Adenovirus Infection

Interventions: Biological: virus-specific T-Cells

First Posted Date: 2016-03-08

Last Posted Date: 2019-05-09

Lead Sponsor: St. Anna Kinderkrebsforschung

Registration Number: NCT02702427

Locations: 🇦🇹
St. Anna Children's Hospital, Vienna, Austria

Pre-existing Kinase Domain Mutations in Ph-positive Leukemias

Recruiting

Conditions: Leukemia

First Posted Date: 2015-12-31

Last Posted Date: 2022-10-31

Lead Sponsor: St. Anna Kinderkrebsforschung

Target Recruit Count: 30

Registration Number: NCT02643888

Locations: 🇦🇹
Medical Universitiy of Vienna, Vienna, Austria

Optimized Diagnostics for Improved Therapy Stratification in Invasive Fungal Infections

Completed

Conditions: Systemic Mycosis

Interventions: Other: Peripheral blood sampling

First Posted Date: 2015-07-08

Last Posted Date: 2021-01-12

Lead Sponsor: St. Anna Kinderkrebsforschung

Target Recruit Count: 244

Registration Number: NCT02492594

Locations: 🇦🇹
Medical University of Vienna, Department of Internal Medicine I, Vienna, Austria
🇦🇹
Hospital Hietzing, Vienna, Austria
🇦🇹
Hanusch Krankenhaus, Vienna, Austria

and more 4 locations

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

Phase 2

Recruiting

Conditions: Acute Lymphoblastic Leukaemia

Interventions: Drug: VP16
Drug: Thiotepa
Radiation: TBI
Drug: Treosulfan
Drug: Fludarabine
Drug: Busulfan
Drug: ATG Thymoglobulin
Drug: Grafalon
Drug: Cyclophosphamide

First Posted Date: 2013-09-24

Last Posted Date: 2024-01-16

Lead Sponsor: St. Anna Kinderkrebsforschung

Target Recruit Count: 1800

Registration Number: NCT01949129

Locations: 🇦🇷
Hospital Sor Maria Ludovica, Department Hematology Stem Cell Transplant Unit, La Plata, Argentina
🇧🇪
University Hospitals Leuven Kinderhemato-oncologie, Leuven, Belgium
🇮🇱
Dana Children's Hospital, Tel Aviv, Israel

and more 115 locations

ch14.18/CHO Bridging Study

Phase 1

Completed

Conditions: Neuroblastoma

Interventions: Drug: ch14.18/CHO

First Posted Date: 2012-10-12

Last Posted Date: 2020-10-22

Lead Sponsor: St. Anna Kinderkrebsforschung

Target Recruit Count: 16

Registration Number: NCT01704872

Locations: 🇩🇪
Charite Children's Hospital, Berlin, Germany
🇮🇹
Gaslini Children's Hospital, Genova, Italy
🇦🇹
St Anna Kinderspital, Vienna, Austria

High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)

Phase 3

Recruiting

Conditions: Neuroblastoma

Interventions: Drug: ch14.18/CHO
Drug: Carboplatin
Drug: Vincristine
Drug: Busulfan
Drug: Aldesleukin
Drug: Etoposide
Drug: Melphalan
Drug: Cisplatin
Drug: Cyclophosphamide
Drug: G-CSF
Drug: Doxorubicin

First Posted Date: 2012-10-11

Last Posted Date: 2020-10-23

Lead Sponsor: St. Anna Kinderkrebsforschung

Target Recruit Count: 3300

Registration Number: NCT01704716

Locations: 🇵🇱
Medical University in Gdansk, Gdansk, Poland
🇵🇱
Children's University Hospital in Lublin, Lublin, Poland
🇵🇱
University of Medical Sciences Poznan, Poznan, Poland

and more 122 locations

Long Term Continuous Infusion ch14.18/CHO Plus s.c. Aldesleukin (IL-2)

Phase 1

Conditions: Neuroblastoma

Interventions: Drug: ch14.18/CHO
Drug: Isotretinoin
Drug: Aldesleukin

First Posted Date: 2012-10-05

Last Posted Date: 2020-07-14

Lead Sponsor: St. Anna Kinderkrebsforschung

Target Recruit Count: 288

Registration Number: NCT01701479

Locations: 🇪🇸
Hospital Universitario La Fe, Valencia, Spain
🇮🇹
Gaslini Children's Hospital, Genova, Italy
🇫🇷
Institut Gustave Roussy, Villejuif, France

and more 11 locations

ALL-SCT BFM International- HSCT in Children and Adolescents With ALL

Phase 3

Conditions: Lymphoblastic Leukemia, Acute, Childhood;

Interventions: Drug: Fludarabine, OKT3, Treosulfan, Thiotepa
Drug: VP16
Drug: VP16, ATG
Radiation: TBI

First Posted Date: 2011-08-26

Last Posted Date: 2015-06-26

Lead Sponsor: St. Anna Kinderkrebsforschung

Target Recruit Count: 405

Registration Number: NCT01423500

Locations: 🇫🇷
Pediatric Immuno-Hematology Unit Robert Debré Hospital, Paris, France
🇳🇱
Leiden University Hospital, Leiden, Netherlands
🇸🇪
Department of Pediatric Oncology, Lund University Hospital, Lund, Sweden

and more 21 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy